Reponex Pharmaceuticals A/S

3 trials 1 recruiting Commercial sponsor

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

1 Recruiting

0 Completed trials

1 Countries active

4 Unique IMPs

N/A Results reported

Phase I/II

Phase I (Other)

Phase I/II: 1 Phase I (Other): 2

Top IMPs

SODIUM CHLORIDE 2 FOSFOMYCIN 1 METRONIDAZOLE 1 MOLGRAMOSTIM 1

All trials

3 total

Intraperitoneal treatment with fosfomycin, metronidazole and recombinant human granulocyte-macrophage colony-stimulating factor in patients … Not authorised

2024-520317-49-00 Phase I (Other) 1 country SODIUM CHLORIDE
Intraperitoneal treatment with fosfomycin, metronidazole and recombinant human granulocyte-macrophage colony-stimulating factor in patients … Pending

2024-520317-49-02 Phase I (Other) 1 country FOSFOMYCIN; METRONIDAZOLE; MOLGRAMOSTIM; SODIUM CHLORIDE
A combined treatment with GM-CSF, fosfomycin and metronidazole for pouchitis in ulcerative colitis patients after restorative ileal pouch an… Recruiting

2024-517764-38-00 Phase I/II 1 country

Showing 1–3 of 3 trials

← All sponsors A–Z